Capricor Therapeutics, Inc. advances research on preserving and protecting muscle at Orlando event

Capricor Therapeutics, Inc. advances research on preserving and protecting muscle at Orlando event
Capricor presents muscle research

Capricor Therapeutics, Inc. is presenting today at the CureDuchenne FUTURES Conference in Orlando, Florida, focusing on cutting-edge developments in muscle preservation, protection, and regeneration for Duchenne muscular dystrophy.

The company is engaging attendees during the Science Main Stage Session, scheduled from 11:00 AM to 12:30 PM ET. Capricor Therapeutics, Inc. aims to highlight emerging approaches in the treatment and management of muscle degeneration. Details on the full conference agenda are available on the official event website.

Capricor Therapeutics recently released its first quarter 2026 financial results and provided a corporate update for investors. The company continues to share developments in its pipeline through both investor communications and scientific forums. Today’s presentation aligns with Capricor’s ongoing efforts to inform stakeholders about key advancements.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.